Ascendis Pharma Community

NasdaqGS:ASND Community

1 Narratives written by author
0 Comments on narratives written by author
4 Fair Values set on narratives written by author

Ascendis Pharma

AN

AnalystConsensusTarget

Consensus Narrative from 15 Analysts

Upcoming SKYTROFA And YORVIPATH Launches Will Expand Global Reach

Key Takeaways Expanding product offerings and market reach, especially through SKYTROFA and YORVIPATH, aims to boost revenue and capture new opportunities. Strong cash reserves enable investment in product development and expansions, potentially leading to diversified revenue and improved margins.

US$212.37

FV

26.8% undervalued

61.25%

Revenue growth p.a.

0

0

1

5 days ago